+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bullous pemphigoid Market - Global Forecast 2026-2032- Product Image
Bullous pemphigoid Market - Global Forecast 2026-2032- Product Image
New

Bullous pemphigoid Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 186 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011507
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bullous pemphigoid market is undergoing measurable transformation, shaped by evolving clinical practices, advancing diagnostics, and emerging therapies. Senior decision-makers across healthcare and life sciences need to navigate complex care pathways, new supply dynamics, and shifting reimbursement models while focusing on safety, cost containment, and patient outcomes.

Bullous Pemphigoid Market Snapshot

The Bullous pemphigoid market grew from USD 379.75 million in 2025 to USD 402.44 million in 2026. It is expected to continue growing at a CAGR of 6.08%, reaching USD 574.14 million by 2032. Steady market expansion reflects advancing therapeutic innovation and increasing demand for improved diagnostic and treatment options in this autoimmune blistering disease.

Scope & Segmentation

  • Therapeutic Classes: Biologics, corticosteroids, immunosuppressants, and steroid-sparing agents are central to evolving treatment strategies.
  • Routes of Administration: Includes intravenous, oral, and topical formulations, each influencing uptake, monitoring needs, and care settings.
  • Distribution Pathways: Hospital pharmacies, retail outlets, specialty clinics, and emerging online platforms serve diverse end-user profiles.
  • End-User Settings: Hospitals (public and private), homecare, dermatology clinics, and outpatient facilities hold distinct roles in diagnosis and ongoing management.
  • Therapy Line: First-line, maintenance, and second-line treatments drive evidence needs around sequencing and safety in elderly populations.
  • Regions: Americas, Europe/Middle East/Africa, and Asia-Pacific, each with unique demographics, regulatory environments, and adoption drivers.

Key Takeaways

  • Diagnostic improvements, such as refined serologic assays and immunofluorescence, support accurate disease differentiation and targeted management.
  • Corticosteroid regimens are shifting toward safer, steroid-sparing therapies as clinicians balance disease control with patient quality of life.
  • Multidisciplinary care, with a focus on dermatology, geriatrics, and immunology, is driving contemporary models that boost outpatient and home-based service adoption.
  • Operational changes, such as enhanced supply chain resilience and digital remote monitoring, are optimizing delivery and supporting decentralized care models.
  • Stakeholder strategies are increasingly oriented toward value-based contracting, real-world evidence generation, and collaborative payer engagement to ensure safe access and reimbursement alignment.
  • Regional market access varies; the Americas lead with specialty care innovation, EMEA requires tailored regulatory and reimbursement approaches, and Asia-Pacific emphasizes cost-containment and growing local production capacity.

Tariff Impact on Supply Chain & Procurement

Recent and projected tariff changes, particularly in the United States, are impacting supply chain costs for active pharmaceutical ingredients and packaging. These adjustments drive manufacturers to explore domestic and nearshoring strategies, diversify sources, and reevaluate procurement and pricing models. Providers face increased scrutiny on contract terms, and payers intensify value assessments to maintain patient access to advanced therapies, especially steroid-sparing alternatives. Distribution networks are also adapting to minimize downstream disruption and sustain treatment continuity.

Methodology & Data Sources

The analysis combines structured clinical expert interviews, secondary research across regulatory documents and published guidelines, and scenario-based supply chain modeling. Multiple data triangulation rounds ensured clinical and operational accuracy, with validation processes involving dermatologists, procurement leads, and payers to capture all pivotal adoption factors.

Why This Report Matters

  • Enables executive teams to anticipate clinical and procurement shifts critical for market positioning in bullous pemphigoid.
  • Delivers actionable insight into tariff impact, supply chain resilience, and cross-regional adoption strategies for effective resource allocation.
  • Supports evidence-based decisions through validated segmentation data, current real-world practices, and emerging therapy trends.

Conclusion

Decision-makers equipped with this market intelligence will more effectively align commercial, clinical, and logistical strategies. Careful coordination across evidence, supply, and payer engagement will establish sustainable and patient-centered bullous pemphigoid care pathways.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Bullous pemphigoid Market, by Drug Class
8.1. Biologics
8.1.1. Omalizumab
8.1.2. Rituximab
8.2. Corticosteroids
8.2.1. Methylprednisolone
8.2.2. Prednisone
8.3. Immunosuppressants
8.3.1. Azathioprine
8.3.2. Methotrexate
8.3.3. Mycophenolate Mofetil
9. Bullous pemphigoid Market, by Route Of Administration
9.1. Intravenous
9.2. Oral
9.3. Topical
10. Bullous pemphigoid Market, by Therapy Line
10.1. First Line
10.2. Maintenance
10.3. Second Line
11. Bullous pemphigoid Market, by End User
11.1. Homecare Settings
11.2. Hospitals
11.2.1. Private Hospitals
11.2.2. Public Hospitals
11.3. Specialty Clinics
11.3.1. Dermatology Clinics
11.3.2. Outpatient Clinics
12. Bullous pemphigoid Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Bullous pemphigoid Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Bullous pemphigoid Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Bullous pemphigoid Market
16. China Bullous pemphigoid Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. AbbVie Inc.
17.6. Argenx SE
17.7. AstraZeneca plc
17.8. Bristol-Myers Squibb Company
17.9. Eli Lilly and Company
17.10. F. Hoffmann-La Roche AG
17.11. GlaxoSmithKline plc
17.12. Novartis AG
17.13. Pfizer Inc.
17.14. Regeneron Pharmaceuticals, Inc.
17.15. Sanofi S.A.
17.16. Sun Pharmaceutical Industries Ltd.
List of Figures
FIGURE 1. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BULLOUS PEMPHIGOID MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BULLOUS PEMPHIGOID MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY THERAPY LINE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA BULLOUS PEMPHIGOID MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY OMALIZUMAB, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY OMALIZUMAB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY OMALIZUMAB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY RITUXIMAB, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY RITUXIMAB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY RITUXIMAB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY METHYLPREDNISOLONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY METHYLPREDNISOLONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY METHYLPREDNISOLONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY PREDNISONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY PREDNISONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY PREDNISONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY AZATHIOPRINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY AZATHIOPRINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY AZATHIOPRINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY METHOTREXATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY METHOTREXATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY METHOTREXATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY MYCOPHENOLATE MOFETIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY MYCOPHENOLATE MOFETIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY MYCOPHENOLATE MOFETIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY FIRST LINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY FIRST LINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY SECOND LINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY SECOND LINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY DERMATOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY DERMATOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 121. EUROPE BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. EUROPE BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 123. EUROPE BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 124. EUROPE BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 125. EUROPE BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 126. EUROPE BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 127. EUROPE BULLOUS PEMPHIGOID MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 128. EUROPE BULLOUS PEMPHIGOID MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. EUROPE BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 130. EUROPE BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST BULLOUS PEMPHIGOID MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST BULLOUS PEMPHIGOID MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 141. AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 143. AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 144. AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 145. AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 146. AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 147. AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 148. AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 150. AFRICA BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. ASEAN BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. ASEAN BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 164. ASEAN BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 165. ASEAN BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 166. ASEAN BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 167. ASEAN BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 168. ASEAN BULLOUS PEMPHIGOID MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 169. ASEAN BULLOUS PEMPHIGOID MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. ASEAN BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 171. ASEAN BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 172. GCC BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. GCC BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 174. GCC BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 175. GCC BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 176. GCC BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 177. GCC BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 178. GCC BULLOUS PEMPHIGOID MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 179. GCC BULLOUS PEMPHIGOID MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. GCC BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 181. GCC BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION BULLOUS PEMPHIGOID MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION BULLOUS PEMPHIGOID MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 192. BRICS BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. BRICS BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 194. BRICS BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 195. BRICS BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 196. BRICS BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 197. BRICS BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 198. BRICS BULLOUS PEMPHIGOID MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 199. BRICS BULLOUS PEMPHIGOID MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. BRICS BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 201. BRICS BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 202. G7 BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 203. G7 BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 204. G7 BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 205. G7 BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 206. G7 BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 207. G7 BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 208. G7 BULLOUS PEMPHIGOID MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 209. G7 BULLOUS PEMPHIGOID MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. G7 BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 211. G7 BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 212. NATO BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. NATO BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 214. NATO BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 215. NATO BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 216. NATO BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 217. NATO BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 218. NATO BULLOUS PEMPHIGOID MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 219. NATO BULLOUS PEMPHIGOID MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. NATO BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 221. NATO BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 222. GLOBAL BULLOUS PEMPHIGOID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 233. CHINA BULLOUS PEMPHIGOID MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 234. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 235. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 236. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 237. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 238. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 239. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 240. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 242. CHINA BULLOUS PEMPHIGOID MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)

Companies Mentioned

  • AbbVie Inc.
  • Argenx SE
  • AstraZeneca plc
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages186
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 402.44 Million
Forecasted Market Value ( USD ) by 2032 $ 574.14 Million
Compound Annual Growth Rate6.0%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Bullous Pemphigoid Market - A Global and Regional Analysis: Focus on Therapy Type and Region - Analysis and Forecast, 2025-2035 - Product Image

Bullous Pemphigoid Market - A Global and Regional Analysis: Focus on Therapy Type and Region - Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Interleukin 13 Inhibitors - Pipeline Insight, 2025 - Product Image

Interleukin 13 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Atopic Dermatitis Drugs Market - Global Forecast 2026-2032 - Product Image

Atopic Dermatitis Drugs Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Systemic Lupus Erythematosus Market - Global Forecast 2025-2032 - Product Image

Systemic Lupus Erythematosus Market - Global Forecast 2025-2032

  • Report
  • 180 Pages
  • Global
From
Chronic Inducible Urticaria Market - A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035 - Product Image

Chronic Inducible Urticaria Market - A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.